Skip to main navigation Skip to search Skip to main content

Gold Nanoparticle-Mediated Gene Therapy

  • University of Sharjah

Research output: Contribution to journal › Review article › peer-review

46 Scopus citations

Abstract

Gold nanoparticles (AuNPs) have gained increasing attention as novel drug-delivery nanostructures for the treatment of cancers, infections, inflammations, and other diseases and disorders. They are versatile in design, synthesis, modification, and functionalization. This has many advantages in terms of gene editing and gene silencing, and their application in genetic illnesses. The development of several techniques such as CRISPR/Cas9, TALEN, and ZFNs has raised hopes for the treatment of genetic abnormalities, although more focused experimentation is still needed. AuNPs, however, have been much more effective in trending research on this subject. In this review, we highlight recently well-developed advancements that are relevant to cutting-edge gene therapies, namely gene editing and gene silencing in diseases caused by a single gene in humans by taking an edge of the unique properties of the AuNPs, which will be an important outlook for future research.

Original languageEnglish
Article number5366
JournalCancers
Volume14
Issue number21
DOIs
StatePublished - Nov 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CRISPR/Cas9 system
  • RNA interference (RNAi)
  • TALENs gene editing
  • antisense oligonucleotides
  • zinc finger nucleases

Fingerprint

Dive into the research topics of 'Gold Nanoparticle-Mediated Gene Therapy'. Together they form a unique fingerprint.

Cite this